Dawn Health and Merck are collaborating to support Growth Disorders care
Copenhagen, Denmark (ots/PRNewswire) - Dawn Health, the digital health company pioneering patient-first innovation, has announced they are working with leading global pharmaceutical company, Merck, on a digital solution for Growth Hormone Disorders (GHD). Over the next two years, they will join forces to deliver a cutting-edge, user-centric digital platform, designed ...
mehr